Skip to main content

Advertisement

SpringerLink
Log in

Anaplastic thyroid carcinoma: An overview

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Thyroid cancer is an uncommon malignancy that accounts for roughly 1% of all new cancers. Although anaplastic lesions constitute fewer than 5% of thyroid cancers, they represent over half of thyroid cancer-related deaths. The relative rarity of anaplastic thyroid cancer, its aggressive nature, and its rapidly fatal course have contributed to the difficulty in developing effective treatment for this disease. Radiation, chemotherapy, and surgery are rarely curative, but combinations of these modalities appear to offer greater benefit than any single treatment. New treatment modalities are desperately required, and promising molecular-based therapies are being investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Sherman SI: Thyroid carcinoma. Lancet 2003, 361:501–511.

    Article  PubMed  Google Scholar 

  2. Thyroid cancer statistics. http://www.cancer.org. Accessed January 11, 2007.

  3. Carcangiu ML, Steeper T, Zampi G, Rosai J: Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 1985, 83:135–158.

    PubMed  CAS  Google Scholar 

  4. Quiros RM, Ding HG, Gattuso P, et al.: Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 2005, 103:2261–2268.

    Article  PubMed  CAS  Google Scholar 

  5. Takashima S, Morimoto S, Ikezoe J, et al.: CT evaluation of anaplastic thyroid carcinoma. AJNR Am J Neuroradiol 1990, 11:361–367.

    PubMed  CAS  Google Scholar 

  6. McIver B, Hay ID, Giuffrida DF, et al.: Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001, 130:1028–1034.

    Article  PubMed  CAS  Google Scholar 

  7. Nel CJ, van Heerden JA, Goellner JR, et al.: Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc 1985, 60:51–58.

    PubMed  CAS  Google Scholar 

  8. Ordonez N, Baloch Z, Tallini G, et al.: Undifferentiated (anaplastic) carcinoma. In World Health Organization Classification of Tumours Pathology and Genetics: Tumours of Endocrine Organs. Edited by DeLellis R A LR, Heitz PH, Eng C. Lyon, France: IARC; 2004:77–80.

    Google Scholar 

  9. LiVolsi V: Undifferentiated or anaplastic carcinoma of the thyroid. In Surgical Pathology of the Thyroid: Major Problems in Pathology. Edited by Bennington J. Philadelphia: WB Saunders; 1990:253–274.

    Google Scholar 

  10. Hunt JL, Tometsko M, LiVolsi VA, et al.: Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol 2003, 27:1559–1564.

    Article  PubMed  Google Scholar 

  11. American Joint Cancer Committee: AJCC Cancer Staging Manual, edn 6. Chicago: AJCC; 2002.

    Google Scholar 

  12. Ain KB: Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 1998, 8:715–726.

    PubMed  CAS  Google Scholar 

  13. O’Neill JP, O’Neill B, Condron C, et al.: Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease. J Laryngol Otol 2005, 119:585–591.

    Article  PubMed  CAS  Google Scholar 

  14. Kihara M, Miyauchi A, Yamauchi A, Yokomise H: Prognostic factors of anaplastic thyroid carcinoma. Surg Today 2004, 34:394–398.

    Article  PubMed  Google Scholar 

  15. Aldinger KA, Samaan NA, Ibanez M, Hill CS Jr: Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer 1978, 41:2267–2275.

    Article  PubMed  CAS  Google Scholar 

  16. Hundahl SA, Fleming ID, Fremgen AM, Menck HR: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 1998, 83:2638–2648.

    Article  PubMed  CAS  Google Scholar 

  17. Schlumberger M, Parmentier C, Delisle MJ, et al.: Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer 1991, 67:564–566.

    Article  PubMed  CAS  Google Scholar 

  18. Nilsson O, Lindeberg J, Zedenius J, et al.: Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg 1998, 22:725–730.

    Article  PubMed  CAS  Google Scholar 

  19. Simpson WJ: Anaplastic thyroid carcinoma: a new approach. Can J Surg 1980, 23:25–27.

    PubMed  CAS  Google Scholar 

  20. Pierie JP, Muzikansky A, Gaz RD, et al.: The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 2002, 9:57–64.

    Article  PubMed  Google Scholar 

  21. Tennvall J, Lundell G, Wahlberg P, et al.: Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 2002, 86:1848–1853.

    Article  PubMed  CAS  Google Scholar 

  22. De Crevoisier R, Baudin E, Bachelot A, et al.: Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys 2004, 60:1137–1143.

    Article  PubMed  Google Scholar 

  23. Haigh PI, Ituarte PH, Wu HS, et al.: Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001, 91:2335–2342.

    Article  PubMed  CAS  Google Scholar 

  24. Kebebew E, Greenspan FS, Clark OH, et al.: Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005, 103:1330–1335.

    Article  PubMed  Google Scholar 

  25. Ain KB, Egorin MJ, DeSimone PA: Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 2000, 10:587–594.

    Article  PubMed  CAS  Google Scholar 

  26. Besic N, Auersperg M, Us-Krasovec M, et al.: Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol 2001, 27:260–264.

    Article  PubMed  CAS  Google Scholar 

  27. Hunt JL: Unusual thyroid tumors: a review of pathologic and molecular diagnosis. Expert Rev Mol Diagn 2005, 5:725–734.

    Article  PubMed  CAS  Google Scholar 

  28. Ito Y, Yoshida H, Tomoda C, et al.: Expression of S100A2 and S100A6 in thyroid carcinomas. Histopathology 2005, 46:569–575.

    Article  PubMed  CAS  Google Scholar 

  29. Guida T, Salvatore G, Faviana P, et al.: Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma. J Clin Endocrinol Metab 2005, 90:4703–4709.

    Article  PubMed  CAS  Google Scholar 

  30. Onda M, Akaishi J, Asaka S, et al.: Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. Br J Cancer 2005, 92:2216–2224.

    Article  PubMed  CAS  Google Scholar 

  31. Pallante P, Berlingieri MT, Troncone G, et al.: UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer 2005, 93:464–471.

    Article  PubMed  CAS  Google Scholar 

  32. Mizutani K, Onda M, Asaka S, et al.: Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer 2005, 103:1785–1790.

    Article  PubMed  CAS  Google Scholar 

  33. Nobuhara Y, Onoda N, Yamashita Y, et al.: Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines. Br J Cancer 2005, 92:1110–1116.

    Article  PubMed  CAS  Google Scholar 

  34. Younes MN KS, Yigitbasi OG, Mandal M, et al.: Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther 2005, 4:1146–1156.

    Article  PubMed  CAS  Google Scholar 

  35. Sorrentino R, Libertini S, Pallante PL, et al.: Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab 2005, 90:928–935.

    Article  PubMed  CAS  Google Scholar 

  36. Nikiforov YE: Editorial: anaplastic carcinoma of the thyroid—will aurora B light a path for treatment? J Clin Endocrinol Metab 2005, 90:1243–1245.

    Article  PubMed  CAS  Google Scholar 

  37. Zhong WB, Liang YC, Wang CY, et al.: Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling. Endocr Relat Cancer 2005, 12:615–629.

    Article  PubMed  CAS  Google Scholar 

  38. Bulgin D PA, Takakura S, Mitsutake N, et al.: Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest. Thyroid 2006, 16:217–224.

    Article  PubMed  CAS  Google Scholar 

  39. Moscetti L, Padalino D, Capomolla E, et al.: A partial response in anaplastic carcinoma of the thyroid with liposomal doxorubicin. J Exp Clin Cancer Res 2005, 24:151–154.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Medical University of South Carolina, 96 Jonathan Lucas Street, Clinical Sciences Building, Suite 420, PO Box 250613, Charleston, SC, 29425, USA

    Wendy R. Cornett MD, MHS

Authors
  1. Wendy R. Cornett MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anand K. Sharma MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Terry A. Day MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mary S. Richardson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rana S. Hoda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jon A. van Heerden MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jyotika K. Fernandes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wendy R. Cornett MD, MHS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cornett, W.R., Sharma, A.K., Day, T.A. et al. Anaplastic thyroid carcinoma: An overview. Curr Oncol Rep 9, 152–158 (2007). https://doi.org/10.1007/s11912-007-0014-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-007-0014-3

Keywords

Search

Navigation